List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape

List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape

Submitted by admin on May 14, 2018 - 9:32am
Source: 
GoinPharma
News Tags: 
Novartis
dermatology
generics
M&A
Aurobindo
Shanghai Fosun Pharmaceutical
Apollo Global Management
Headline: 
List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape
snippet: 

A list of likely buyers of Novartis’ US dermatology generics division, valued at an approximate $2bn, is now drawn up, Bloomberg has reported. 

Do Not Allow Advertisers to Use My Personal information